cupric sulfide has been researched along with singlet oxygen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Dong, C; Han, J; Hu, X; Liang, S; Lu, Y; Shi, S; Yao, T; Zhou, L | 1 |
| Dong, XJ; Dong, YB; Guan, Q; Li, WY; Li, YA | 1 |
2 other study(ies) available for cupric sulfide and singlet oxygen
| Article | Year |
|---|---|
Post-synthesis strategy to integrate porphyrinic metal-organic frameworks with CuS NPs for synergistic enhanced photo-therapy.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Coloring Agents; Copper; Drug Screening Assays, Antitumor; Humans; Hyperthermia, Induced; Indocyanine Green; Infrared Rays; Materials Testing; Metal-Organic Frameworks; Nanoparticles; Optical Imaging; Particle Size; Photochemotherapy; Singlet Oxygen; Surface Properties; Tumor Cells, Cultured | 2020 |
A CuS- and BODIPY-loaded nanoscale covalent organic framework for synergetic photodynamic and photothermal therapy.
Topics: Antineoplastic Agents; Boron Compounds; Cell Proliferation; Cell Survival; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Metal-Organic Frameworks; Molecular Structure; Particle Size; Photosensitizing Agents; Photothermal Therapy; Singlet Oxygen; Structure-Activity Relationship | 2022 |